UNSPSC 41131620: Quality control kit for blood banking reagents

In this classification, a quality control kit for blood banking reagents is a device that consists of sera, cells, buffers, and antibodies used to determine the specificity, potency, and reactivity of the cells and reagents used for blood banking. US FDA regulates Quality control kit for blood banking reagents under 21 CFR 864.9650 and under FDA product code KSF.

UNSPSC 41131620 Quality control kit for blood banking reagents is a Commodity code that state and local governments procure primarily as part of blood transfusion equipment and emergency medical services infrastructure. The recent activity shows little direct solicitation of standalone quality control kits; instead, issuers are buying integrated blood transfusion systems and related consumables through their emergency medical or public health procurement channels. The California Emergency Medical Services Board (EMSB) solicited blood transfusion equipment including the Qinflow Warrior Blood Warmer system and associated consumable bags under Measure B funding, representing the type of integrated medical equipment purchase that would encompass quality control components. State and local buyers include emergency medical services authorities, health departments, and fire rescue departments that operate transfusion or blood-handling programs.

Recent activity is concentrated in California and Florida. The EMSB posted an IFB (RFBIS27200126) on August 24, 2026 with a response date of September 9, 2026 for blood transfusion equipment serving multiple EMSB facilities throughout California; the Hillsborough County Board of County Commissioners posted an ITB (ITB2600319) on July 7, 2026 with a response date of July 24, 2026 for consumable operational supplies including items for its 47 fire rescue stations, with an estimated contract value of $765,679.84. The California procurement requires Certified Business Enterprise (CBE) certification as a prerequisite for bid eligibility. The code shows limited recent standalone procurement activity specific to quality control kits for blood banking reagents alone; opportunities tend to bundle such items with larger blood transfusion system buys or general medical supply contracts.